Barbara-Jean Anne Bormann-Kennedy insider trades

Open-market stock purchases and sales by Barbara-Jean Anne Bormann-Kennedy, Director at Xeris Biopharma Holdings, Inc, from SEC Form 4 filings since Feb 27, 2019.

Recent trades

DateStockTradeValue
Jun 4, 2026XERS Xeris Biopharma Holdings, IncSold$97.5K
Jun 4, 2026XERS Xeris Biopharma Holdings, IncBought (not open market)—
Jun 4, 2026XERS Xeris Biopharma Holdings, IncBought (not open market)$203K
Dec 12, 2025XERS Xeris Biopharma Holdings, IncSold$106K

Companies traded

  • XERS Xeris Biopharma Holdings, Inc: 2 sales, last Jun 4, 2026

Get free alerts when Barbara-Jean Anne Bormann-Kennedy files a new trade →